Brainstorm Cell Stock (NASDAQ: BCLI) stock price, news, charts, stock research, profile.
Open | $0.34 |
Close | $0.37 |
Volume / Avg. | 1.08M / 771.77K |
Day Range | 0.34 - 0.37 |
52 Wk Range | 0.13 - 2.13 |
Market Cap | $24.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.29% |
Days to Cover | 1.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Brainstorm Cell (NASDAQ:BCLI) through any online brokerage.
Other companies in Brainstorm Cell’s space includes: Vincerx Pharma (NASDAQ:VINC), Gain Therapeutics (NASDAQ:GANX), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Lisata Therapeutics (NASDAQ:LSTA).
There is no analysis for Brainstorm Cell.
Brainstorm Cell has a consensus price target of $0.00.
The stock price for Brainstorm Cell (NASDAQ: BCLI) is $0.351 last updated July 5, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Brainstorm Cell.
Brainstorm Cell’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Brainstorm Cell.
Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.